Published on 23 Feb 2024 on Zacks via Yahoo Finance
Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?
Nurix Therapeutics, Inc. (NRIX) shares ended the last trading session 5.1% higher at $10.55. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 29.2% gain over the past four weeks.
The stock rallied driven by the growing optimism over the drug biotech sector in 2024.
This company is expected to post quarterly loss of $0.83 per share in its upcoming report, which represents a year-over-year change of -10.7%. Revenues are expected to be $14.28 million, up 12.5% from the year-ago quarter.